Literature DB >> 9495306

Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: role of adenosine.

K Hata1, P Whittaker, R A Kloner, K Przyklenk.   

Abstract

BACKGROUND: Recent studies suggest that patients with angina before myocardial infarction exhibit improved recovery of coronary perfusion after thrombolysis by an as-yet-unknown mechanism. We therefore proposed that brief antecedent ischemia/reperfusion may, via release of adenosine, improve vessel patency in damaged and stenotic coronary arteries. METHODS AND
RESULTS: Anesthetized dogs underwent coronary injury + stenosis, resulting in repeated cyclic variations in coronary blood flow (CFVs) caused by the formation/dislodgment of platelet-rich thrombi. Vessel patency was assessed for 3 hours after stenosis by quantification of the nadir of the CFVs, duration of total thrombotic occlusion (flow=0), and area of the flow-time profile (expressed as percent of baseline flow x 180 minutes). In protocol 1, dogs received 10 minutes of coronary occlusion + 10 minutes of reflow or a comparable 20-minute control period before injury + stenosis. The median nadir of the CFVs was higher (4.0 versus 0.3 mL/min), median zero flow duration per 30-minute time interval was shorter (0.4 versus 15.1 minutes), and mean percent flow-time area was greater (54+/-8% versus 28+/-9%) in dogs that received antecedent ischemia versus controls (P<.05). These benefits of antecedent ischemia/reperfusion were largely mimicked by a 10-minute intracoronary adenosine infusion (400 microg/min) in lieu of brief ischemia (protocol 2) and were abolished by administration of the adenosine A1/A2 receptor antagonist PD 115,199 (3 mg/kg i.v.) before brief antecedent coronary occlusion (protocol 3).
CONCLUSIONS: Brief antecedent ischemia attenuates subsequent platelet-mediated thrombosis in damaged and stenotic canine coronary arteries, due, in large part, to an adenosine-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9495306     DOI: 10.1161/01.cir.97.7.692

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Effects of repeated brief episodes of ischemia and reperfusion in isolated perfused rat hearts.

Authors:  T Yasumura; N Aoki; A Yanagisawa; A Maki; C Shirato; K Ishikawa
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 3.  [Myocardial preconditioning with volatile anesthetics. General anesthesia as protective intervention?].

Authors:  H Buchinger; U Grundmann; S Ziegeler
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

4.  In vitro platelet responsiveness to adenosine-mediated "preconditioning" is age-dependent.

Authors:  Karin Przyklenk; Peter Whittaker
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

5.  Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction.

Authors:  D Rimar; E Crystal; A Battler; S Gottlieb; D Freimark; H Hod; V Boyko; L Mandelzweig; S Behar; J Leor
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 6.  Thrombus aspiration in primary angioplasty for ST-segment elevation myocardial infarction.

Authors:  Roberta Serdoz; Michele Pighi; Nikolaos V Konstantinidis; Ismail Dogu Kilic; Sara Abou-Sherif; Carlo Di Mario
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

7.  Fibrin architecture in clots: a quantitative polarized light microscopy analysis.

Authors:  Peter Whittaker; Karin Przyklenk
Journal:  Blood Cells Mol Dis       Date:  2008-12-02       Impact factor: 3.039

8.  Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis.

Authors:  Thomas Gremmel; Ivan B Yanachkov; Milka I Yanachkova; George E Wright; Joseph Wider; Vishnu V R Undyala; Alan D Michelson; Andrew L Frelinger; Karin Przyklenk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-07       Impact factor: 8.311

9.  Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis.

Authors:  K Przyklenk; A L Frelinger; M D Linden; P Whittaker; Y Li; M R Barnard; J Adams; M Morgan; H Al-Shamma; A D Michelson
Journal:  J Thromb Haemost       Date:  2009-11-17       Impact factor: 5.824

10.  Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models.

Authors:  Matthew D Linden; Marc R Barnard; A L Frelinger; Alan D Michelson; Karin Przyklenk
Journal:  Thromb Res       Date:  2007-08-28       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.